![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 7645-7647, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
against Hepatitis B Virus
Can Be Studied in Non-hepatic Cells and Is Independent of MxA*
,
From the Heinrich-Pette-Institut für Experimentelle Virologie
und Immunologie an der Universität Hamburg, Martinistraße
52, 20251 Hamburg, Germany
It is well established that interferon-
can
induce non-cytotoxic intracellular suppression of hepatitis B virus
replication, but the mechanisms involved are unclear. Cell culture
studies to characterize these mechanisms are restricted, in part
because hepatitis B virus replicates almost exclusively in
liver-derived cells. To overcome this limitation we used a
cytomegalovirus promoter-controlled hepatitis B virus expression
system, which leads to intracellular viral replication even in
non-hepatic cell lines. In this experimental system interferon-
treatment specifically suppressed viral replication demonstrating that
antiviral activities against hepatitis B virus are not restricted to
hepatic cells. Furthermore, the interferon-inducible MxA protein was
recently reported to play a key role in the antiviral action of
interferon-
against hepatitis B virus. Our data demonstrate that
interferon-
also suppresses hepatitis B virus replication in
MxA-deficient HEp2 cells, indicating that MxA is not essential for
these activities. Taken together, our data imply that the experimental
approach presented can also be adapted to established cell lines which
are deficient in parts of the signal transduction pathway or other
elements located further downstream, providing important insights into
mechanisms specifically suppressing hepatitis B virus.
To whom correspondence should be addressed: Bundesinstitut
für Gesundheitlichen Verbraucherschutz und
Veterinärmedizin, Thielallee 88-92, 14195 Berlin, Germany. Tel.:
49-188-8412-3716; Fax: 49-188-8412-3635; E-mail:
a.rang@bgvv.de.
This article has been cited by other articles:
![]() |
O. Schildgen, H. Sirma, A. Funk, C. Olotu, U. C. Wend, H. Hartmann, M. Helm, J. K. Rockstroh, W. R. Willems, H. Will, et al. Variant of hepatitis B virus with primary resistance to adefovir. N. Engl. J. Med., April 27, 2006; 354(17): 1807 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ehlers, S. Horke, K. Reumann, A. Rang, F. Grosse, H. Will, and T. Heise Functional Characterization of the Interaction between Human La and Hepatitis B Virus RNA J. Biol. Chem., October 15, 2004; 279(42): 43437 - 43447. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fiedler, F. Rodicker, V. Salucci, M. Lu, L. Aurisicchio, U. Dahmen, L. Jun, O. Dirsch, B. M. Putzer, F. Palombo, et al. Helper-Dependent Adenoviral Vector-Mediated Delivery of Woodchuck-Specific Genes for Alpha Interferon (IFN-{alpha}) and IFN-{gamma}: IFN-{alpha} but Not IFN-{gamma} Reduces Woodchuck Hepatitis Virus Replication in Chronic Infection In Vivo J. Virol., September 15, 2004; 78(18): 10111 - 10121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Wieland, R. G. Vega, R. Muller, C. F. Evans, B. Hilbush, L. G. Guidotti, J. G. Sutcliffe, P. G. Schultz, and F. V. Chisari Searching for Interferon-Induced Genes That Inhibit Hepatitis B Virus Replication in Transgenic Mouse Hepatocytes J. Virol., December 20, 2002; 77(2): 1227 - 1236. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |